Cutler Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-39,300
Closed -$2K 6248
2021
Q4
$2K Sell
39,300
-16,000
-29% -$24.7K ﹤0.01% 4873
2021
Q3
$19K Sell
55,300
-121,200
-69% -$272K ﹤0.01% 3404
2021
Q2
$275K Sell
176,500
-36,000
-17% -$90K 0.01% 1122
2021
Q1
$316K Buy
212,500
+63,800
+43% +$231K 0.02% 982
2020
Q4
$25K Buy
+148,700
New +$68K ﹤0.01% 2521
2018
Q3
Sell
-292
Closed -$1K 4841
2018
Q2
$1K Buy
+292
New +$10.6K ﹤0.01% 4011
2016
Q3
Sell
-1,331
Closed -$1K 7532
2016
Q2
$1K Buy
1,331
+539
+68% +$16.9K ﹤0.01% 6337
2016
Q1
$3K Buy
+792
New +$33.9K ﹤0.01% 5377

Other funds holding ASXC

Cutler Group's ASXC Position: Q1 2023 in Review

Cutler Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2023, closing a stake of 36,258 shares — an estimated $12K sold.

Cutler Group first reported a position in ASXC in Q4 2015 and held it in 23 quarters. The position peaked at $119K in Q2 2021. 79 funds tracked by Wall St. Rank hold ASXC as of Q1 2023.

  • Cutler Group reported no remaining Asensus Surgical, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 36,258 Asensus Surgical, Inc. shares in Q1 2023, an estimated $12K.
  • Cutler Group first reported a position in Asensus Surgical, Inc. in Q4 2015 and held it in 23 quarters.
  • Cutler Group's Asensus Surgical, Inc. position peaked at $119K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.